Adverse cutaneous reactions secondary to tyrosine kinase inhibitors including imatinib mesylate, nilotinib, and dasatinib

Lichenoid Drug Eruption with Palmoplantar Hyperkeratosis due to Imatinib Mesylate: A Case Report and a Review of the Literature

(2010) N Kuraishi et al.   ACTA DERMATO-VENEREOLOGICA

Cutaneous Lichenoid Eruption Caused by Imatinib Mesylate in a Japanese Patient with Chronic Myeloid Leukaemia

(2009) T Kawakami et al.   ACTA DERMATO-VENEREOLOGICA

Disappearance of Lentigines in a Patient Receiving Imatinib Treatment for Familial Gastrointestinal Stromal Tumor Syndrome

(2009) Tracy Campbell et al.   ARCHIVES OF DERMATOLOGY

Imatinib: a designer drug, another cutaneous complication

(2009) E. Dickens et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects

(2009) Jorg Hartmann et al.   CURRENT DRUG METABOLISM

The toxicities of modern targeted therapies—learning from the price of progress

(2009) Francis J. Giles   Targeted Oncology

Bullous Sweet Syndrome in a Patient With t(9;22)(q34;q11)-Positive Chronic Myeloid Leukemia Treated With the Tyrosine Kinase Inhibitor Nilotinib

(2008) Kjell Matthias Kaune et al.   ARCHIVES OF DERMATOLOGY

Is imatinib mesylate a promising drug in systemic sclerosis?

(2008) P. L. A. van Daele et al.   ARTHRITIS AND RHEUMATISM

Imatinib mesylate treatment of nephrogenic systemic fibrosis

(2008) Jonathan Kay et al.   ARTHRITIS AND RHEUMATISM

Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis

(2008) Alfiya Akhmetshina et al.   FASEB JOURNAL

Chemotherapeutic agents and the skin: An update

(2008) Noushin Heidary et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Imatinib-associated hyperpigmentation, a side effect that should be recognized

(2008) T Mcpherson et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Intracellular tyrosine kinases as novel targets for anti-fibrotic therapy in systemic sclerosis

(2008) J. H. W. Distler et al.   RHEUMATOLOGY

A novel therapeutic approach to the treatment of scleroderma-associated pulmonary complications: safety and efficacy of combination therapy with imatinib and cyclophosphamide

(2008) I. Sabnani et al.   RHEUMATOLOGY

Skin and oral lesions associated to imatinib mesylate therapy

(2008) Fernanda Gonçalves Basso et al.   SUPPORTIVE CARE IN CANCER